Clinical Trials on Degenerative Disc Disease in Mexico

Total 7823 results

NuVasive

Completed

Osteocel® Plus in Posterior Lumbar Interbody Fusion (PLIF)

Degenerative Disc Disease

United States
NuVasive

Completed

An Evaluation of Interlaminar Lumbar Instrumented (ILIF™) (ILIF)

Degenerative Disc Disease

United States
NuVasive

Terminated

A Clinical Trial Evaluating a Total Disc Replacement in Patients With Cervical Disc Disease (CerPass)

Cervical Disc Disease

Mexico
American British Cowdray Medical Center

Unknown

Intra-operatory Neurophysiological Monitoring Changes as a Predictive Clinical Outcome Measure in Lumbar Radiculopathy.

Lumbar Disc Disease

Mexico
Asociación para Evitar la Ceguera en México

Terminated

Comparison of the Effects of Bevacizumab Before vs After Pattern Panretinal Photocoagulation

Macular Edema

Mexico
Medtronic Spinal and Biologics

Active, not recruiting

5-Year Global Study on MAST™ Minimally Invasive Fusion Procedures to Treat Degenerative Lumbar Spine (MASTERS-D2) (MASTERS-D2)

Intervertebral Disc Degeneration

United Kingdom, Belgium, Germany, China, Spain, Denmark, Austria, Argentina, Brazil, Czechia, France, Italy, Korea, Republic of, Mexico, Portugal, Russian Federation, Slovakia
Asociación para Evitar la Ceguera en México

Withdrawn

Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)

Cystoid Macular Edema

Mexico
Hospital Civil de Guadalajara

Completed

Non-surgical Spinal Decompression in Patients With Chronic Low Back Pain

Low Back Pain | Sciatica | Lumbar Disc Herniation

Mexico
American British Cowdray Medical Center

Unknown

Improvement of Trans-operatory X-ray Visualization During Anterior Cervical Surgery

Cervical Disk Disease

Mexico
Asociación para Evitar la Ceguera en México

Terminated

Intravitreal Bevacizumab for Age-Related Macular Degeneration

Age Related Macular Degeneration

Mexico
Asociación para Evitar la Ceguera en México

Terminated

Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular Degeneration

Age Related Macular Degeneration

Mexico
Allegro Ophthalmics, LLC

Completed

A Safety And Efficacy Study Of ALG-1001 In Human Subjects With Wet Age-Related Macular Degeneration

Macular Degeneration

Mexico
Asociación para Evitar la Ceguera en México

Terminated

Efficacy of Retreatments With Intravitreal Bevacizumab

Age Related Macular Degeneration | Choroidal Neovascularization

Mexico
Asociación para Evitar la Ceguera en México

Terminated

Effect of Topical Nepafenac in Macular Thickening Related to Pan-retinal Photocoagulation (NEPAF)

Macular Edema | Macular Thickening

Mexico
Oraya Therapeutics, Inc.

Unknown

Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

Eye Diseases | Age-Related Macular Degeneration | Macular Degeneration | Retinal Diseases | Wet Age-Related Macular Degeneration

Mexico
Asociación para Evitar la Ceguera en México

Withdrawn

Bevacizumab and Retinal Vascular Occlusions

Vascular Occlusion | Edema Macular

Mexico
Allegro Ophthalmics, LLC

Withdrawn

Safety Study of ALG- 1001 to Treat Diabetic Macular Edema

Diabetic Macular Edema

Mexico
Asociación para Evitar la Ceguera en México

Completed

Short-term Effect of Intravitreal Dexamethasone Implant in Refractory Diabetic Macular Edema

Diabetic Macular Edema

Mexico
Asociación para Evitar la Ceguera en México

Withdrawn

POSTERIOR SUB-TENON'S Avastin

Diffuse Diabetic Macular Edema

Mexico
Laboratorios Sophia S.A de C.V.

Recruiting

Clinical Study to Evaluate PRO-169 for Diabetic Macular Edema (PRO-169)

Diabetic Macular Edema

Colombia, Mexico
Asociación para Evitar la Ceguera en México

Withdrawn

Avastin for Post-photocoagulation Macular Edema

Macular Edema

Mexico
Asociación para Evitar la Ceguera en México

Withdrawn

Vitrectomy Without Internal Limiting Membrane Removal in the Treatment of Diffuse Diabetic Macular Edema: a Comparative Kenalog Vs Bevacizumab Intravitreal Injection Vs Control Study

Diffuse Diabetic Macular Edema

Mexico
Progen Pharmaceuticals

Completed

Safety of 16.5 mg (3.3%) CGC-11047 Once Every 2 Weeks vs. Once Every 4 Weeks in Patients With CNV Due to AMD

Age Related Macular Degeneration

United States, Mexico, Russian Federation
Instituto Nacional de Cardiologia Ignacio Chavez
Instituto Nacional de Rehabilitacion

Unknown

Effects of Allopurinol on Inflammation and Ultrasonographic Changes in People With Elevated Uric Acid But no Symptoms

Inflammation | Hyperuricemia | Musculoskeletal Degeneration

Mexico
Asociación para Evitar la Ceguera en México

Terminated

Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO (MECROV)

Central Retinal Vein Occlusion | Macular Edema

Mexico
Asociación para Evitar la Ceguera en México

Terminated

Vitrectomy and Bevacizumab for Diffuse Diabetic Macular Edema

Diffuse Diabetic Macular Edema

Mexico
Hospital Juarez de Mexico

Unknown

Efficacy of Dorzolamide as an Adjuvant After Focal Photocoagulation in Clinically Significant Macular Edema

Diabetic Retinopathy | Diabetic Macular Edema

Mexico
Hospital Juarez de Mexico

Completed

Contrast Sensitivity and Diabetic Macular Edema

DIABETES MELLITUS | DIABETIC RETINOPATHY | MACULAR EDEMA

Mexico
National Institute of Rehabilitation, Mexico

Completed

Lumbar Stabilization Exercises vs Flexor Exercises in Degenerative Spondylolisthesis

Chronic Low Back Pain | Degenerative Spondylolisthesis

Mexico
Asociación para Evitar la Ceguera en México

Withdrawn

Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema

Diabetic Macular Edema | Diabetes Mellitus Type 2

Mexico
Bayer

Completed

Study to Gather Information on the Safety and Use of Aflibercept Injections Into the Eye for the Treatment of Eye Disorders in Mexican Routine Clinical Practice (MAIA)

Retinal Disease

Mexico
Instituto Nacional de Ciencias Medicas y Nutricion...

Active, not recruiting

Personalized Nutrition Based on the Glycemic Response: Effect of Diet and Intestinal Microbiota

Obesity | Pre Diabetes

Mexico
Bayer

Completed

A Study in Patients With Wet Age-related Macular Degeneration or Diabetic Macular Edema to Assess the freQuency of Use of Intravitreal Aflibercept in Routine Clinical Practices in Latin America (AQUILA)

Macular Degeneration

Mexico, Argentina, Colombia, Costa Rica
Instituto Nacional de Ciencias Medicas y Nutricion...
Fundación Gonzalo Río Arronte

Recruiting

Postprandial Glucose Levels, Gut Microbiota and Supplementation With Functional Foods in Adults (PPGR)

Healthy | Nutritional and Metabolic Diseases

Mexico
2C Tech Corp

Completed

Intravitreal Injection of SeeQ CdSe 655 Alt Nanoparticles for Patients With Degenerative Retinal Diseases

Retinitis Pigmentosa

Mexico
Laboratorios Silanes S.A. de C.V.
Instituto Mexicano del Seguro Social

Completed

BIOAVAILABILITY OF GLI/METXR (4/850 mg) (GLMT12-SIL)

Healthy

Mexico
CMN "20 de Noviembre"

Completed

Distal Transradial Access for Coronary Angiography and Percutaneous Coronary Intervention.

Coronary Artery Disease

Mexico
Hospital Infantil de Mexico Federico Gomez

Unknown

Comparison of the Impact of Diet vs Thiazide in BMD in Children With Idiopathic Hypercalciuria (HIC)

Nephrolithiasis | Hypercalciuria; Idiopathic

Mexico
Instituto Nacional de Cancerologia de Mexico
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran; Instituto... and other collaborators

Recruiting

Improving Lifestyle Behavior by "Joven, Fuerte y Saludable" Multidisciplinary Program.

Breast Neoplasm

Mexico
Instituto Nacional de Rehabilitacion
National Council of Science and Technology, Mexico

Completed

Robotic Gait Training in Spinal Cord Injury

Spinal Cord Injuries

Mexico
Laboratorios Silanes S.A. de C.V.
Instituto Mexicano del Seguro Social

Completed

BIOAVAILABILITY OF Glimepiride/Extended Release Metformin (GLI/METXR): High Fat Diet Study (GLMT13)

Healthy

Mexico
Asociación para Evitar la Ceguera en México

Withdrawn

Unilateral Bevacizumab for Bilateral Diabetic Macular Edema

Diabetic Retinopathy | Diabetic Macular Edema

Mexico
Instituto Nacional de Cardiologia Ignacio Chavez

Completed

Conventional Hemodialysis Versus Post-Dilution Hemofiltration in Incident RRT (DA-VINCI)

Cognitive Impairment | Hemodialysis Complication | Cerebral Edema | Dialysis; Complications

Mexico
Coordinación de Investigación en Salud, Mexico
Hospital Infantil de Mexico Federico Gomez

Unknown

Effectiveness of Cinnamon on Insulin Resistance ( ECIRCCOS ) December 1, 2019 (ECIRCCOS)

Insulin Resistance | Obesity, Childhood | Insulin Sensitivity

Mexico
Centro Interdisciplinario de Ciencias de la Salud...

Unknown

Design of a Protocol for Obtaining Genomic DNA From Saliva (DPOGDNAS)

Periodontal Disease "Unrecognized Condition"

Mexico
Instituto Nacional de Cardiologia Ignacio Chavez
Salvador López Gil; Armando Vázquez Rangel

Unknown

Effect of Allopurinol or Febuxostat to Prevent Contrast Induced Acute Kidney Injury (CI-AKI) (CI-AKI)

Contrast-induced Nephropathy | Contrast-induced Acute Kidney Injury

Mexico
Instituto Nacional de Ciencias Medicas y Nutricion...

Terminated

Use of Spironolactone for the Prevention of Electrolyte Abnormalities in Patients Treated With Amphotericin B

Patients With Fungic Infections

Mexico
JOSE MANUEL ARREOLA GUERRA
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Completed

Efficacy of Fosfomycin-Trometamol in Urinary Tract Infection Prophylaxis After Kidney Transplantation

Urinary Tract Infection | Hospitalization | Asymptomatic Bacteriuria | Allograft Rejection | Microbiologic Resistance

Mexico
University of New Mexico

Completed

Visual Activity Evoked by Infrared in Humans After Dark Adaptation

Retinitis Pigmentosa | Age Related Macular Degeneration | Congenital Stationary Night Blindness | Colorblindness

United States
NKGen Biotech, Inc.

Terminated

Safety of SNK01 in Subjects With Alzheimer's Disease (ASK-AD) (ASK-AD)

Alzheimer Disease | Neuro-Degenerative Disease

Mexico

Clinical Trials on Degenerative Disc Disease in Mexico

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cambodia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations